Filing Details
- Accession Number:
- 0001209191-21-059131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-04 18:11:27
- Reporting Period:
- 2021-09-29
- Accepted Time:
- 2021-10-04 18:11:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107421 | Ziopharm Oncology Inc | ZIOP | Pharmaceutical Preparations (2834) | 841475642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1846045 | Jaime Vieser | C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-29 | 100,000 | $1.91 | 705,321 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100,000 | Indirect | By UTMA for child |
| Common Stock | 75,000 | Indirect | By UTMA for child |
| Common Stock | 75,000 | Indirect | By UTMA for child |
| Common Stock | 75,000 | Indirect | By UTMA for child |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90to $1.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securitiesand Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
